Core Viewpoint - Red Robin Gourmet Burgers, Inc. has announced its "First Choice" plan aimed at enhancing long-term shareholder value and provided an updated financial outlook for the second quarter of fiscal 2025 [1][2]. Group 1: First Choice Plan - The "First Choice" plan is designed to make Red Robin the preferred choice for guests, team members, and investors through coordinated initiatives [2][3]. - Key components of the plan include protecting the foundations of the previous North Star Plan, driving traffic through creative engagement, managing expenses to reduce debt, investing in restaurant facilities, and fostering a high-performance work environment [3][4]. Group 2: Financial Outlook - The company expects second quarter comparable restaurant sales to decrease by approximately 4%, slightly worse than the previous expectation of a 3% decrease [5]. - Adjusted EBITDA is anticipated to exceed prior expectations of $13 million to $16 million, indicating improved profitability [5][6]. - The first half of 2025 is projected to show Adjusted EBITDA surpassing the full-year results of 2024, reflecting operational excellence and cost efficiency [6]. Group 3: Investor Communication - An investor conference call is scheduled for July 15, 2025, to discuss the "First Choice" plan and updated financial expectations [7]. - The call will be accessible via phone and will also be webcast live, with a replay available shortly after the call [8].

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Core Points - Microsoft experienced a malfunction in its Outlook email service for several hours, affecting Outlook.com, mobile apps, and desktop programs [1] - The issue began at 6:20 p.m. Eastern time on Wednesday, with a fix being rolled out by Microsoft by 12:21 p.m. ET on Thursday [1] - Microsoft announced that configuration changes had resolved the impact in targeted infrastructure and were being deployed worldwide [2] Summary by Sections Service Disruption - The Outlook email service malfunctioned for several hours, leading to user complaints on social media about access issues [1] - The disruption started at 6:20 p.m. ET on Wednesday and affected multiple platforms [1] Resolution Efforts - Microsoft reported that a fix was being implemented by 12:21 p.m. ET on Thursday [1] - The company stated that most impacted users would experience relief within two hours of the fix being deployed [2] - Ongoing monitoring of the service was confirmed by Microsoft [2]

Core Viewpoint - The Centene class action lawsuit alleges that Centene Corporation and its executives misled investors regarding the company's revenue outlook and growth potential during the specified class period, leading to significant financial losses for shareholders [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Lunstrum v. Centene Corporation and covers the period from December 12, 2024, to June 30, 2025 [1]. - The lawsuit claims that Centene provided false information about its projected revenue and growth, particularly regarding enrollment rates and morbidity [3]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, resulting in a significant stock price drop of over 40% [4]. Group 2: Financial Impact - The preliminary analysis indicated that over two-thirds of Centene's marketplace share showed lower-than-anticipated enrollment and increased morbidity, contradicting the company's optimistic reports [3]. - Following the withdrawal of guidance, Centene's adjusted diluted EPS was reduced to approximately $2.75, with a total guidance reduction to about $1.8 billion [4]. Group 3: Legal Process - Investors who suffered losses during the class period can seek to become the lead plaintiff in the lawsuit, representing the interests of all class members [5]. - The lead plaintiff has the authority to select a law firm for litigation and does not need to be the lead plaintiff to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for securing significant monetary relief for investors and has a strong track record in handling large securities class action recoveries [6].

FARMINGTON, Conn., July 9, 2025 /PRNewswire/ -- Otis Worldwide Corporation (NYSE: OTIS) will host a conference call on Wednesday, July 23, 2025, at 8:30 a.m. ET. Otis Chair, CEO & President Judy Marks and Executive Vice President & CFO Cristina Mendez will discuss the company's second quarter results and 2025 outlook.We encourage you to join through our webcast link. A corresponding presentation and news release will be available on www.otis.com prior to the call and a recording will be available on the web ...

Core Viewpoint - Orion Corporation has upgraded its full-year outlook for 2025 due to better-than-expected product sales and royalty income in the first half of the year, which is anticipated to continue for the remainder of the year [1][2]. Financial Outlook - The new full-year outlook estimates net sales to be between EUR 1,630 million and EUR 1,730 million, and operating profit to be between EUR 400 million and EUR 500 million [3]. - The previous outlook estimated net sales between EUR 1,550 million and EUR 1,650 million, and operating profit between EUR 350 million and EUR 450 million [4]. Milestone Payments - The 2025 outlook does not include any material milestone payments, although Orion is entitled to receive a milestone payment of EUR 180 million from Bayer related to the sale of Nubeqa® [2]. - There is uncertainty regarding the timing of this milestone payment, which is why it has not been included in the 2025 outlook estimate [2].

The 9 numbers from 2025 so far that you need to know: https://t.co/AGuTfYQDLF https://t.co/rAhdQtEqra ...

INVITATION TO THE MEDIA & ANALYST WEBCAST July 25, 2025, 11:00 a.m. Half year results 2025 and outlook Steinhausen, July 4, 2025 – We cordially invite you to the media, analyst and investor conference of Schweiter Technologies. In addition to information on the 2025 half year results, we are pleased to give you an outlook for the second half year. The webcast will take place on July 25, 2025 at 11:00 a.m. CEST and can be accessed with this link: https://www.webcast-eqs.com/schweiter-2025-h1. Roman Sondere ...

🚨 ALERT: Microsoft has suspended around 3,000 Outlook and Hotmail accounts tied to a North Korean IT worker infiltration scheme. https://t.co/K393TWNmUQ ...

Core Insights - The health insurance sector is facing significant challenges due to rising medical costs, which are impacting profitability across the industry [3][12] - Oscar Health's stock, currently priced around $17, is considered a potential buying opportunity despite being 30% below its 52-week peak [4][5] - Oscar Health has shown strong revenue growth, with a 59% average increase over the last three years, and a 54.2% rise in revenues from $6.5 billion to $10 billion in the past 12 months [15] Industry Overview - Centene's retraction of its financial outlook led to a 40% decline in its stock, causing a ripple effect in the health insurance sector, with Oscar Health down 19%, UnitedHealth down 6%, Molina down 22%, and CVS down 4% [2] - The increase in medical costs is attributed to a higher number of less healthy individuals enrolling, an increase in medical procedures, and persistently high drug prices [3] Company Performance - Oscar Health's current valuation metrics indicate it is slightly undervalued compared to the S&P 500, with a price-to-sales (P/S) ratio of 0.5 versus 3.1 for the S&P 500 [6][8] - The company's profit margins are significantly lower than most companies within the Trefis coverage universe, reflecting the industry's typical thin margins [9][12] - Oscar Health's balance sheet is robust, with a low Debt-to-Equity Ratio of 5.8% compared to 19.4% for the S&P 500, and a strong Cash-to-Assets Ratio of 51.1% [10][15] Financial Metrics - Oscar Health's operating cash flow (OCF) was $1.2 billion, with a low OCF margin of 12.1% compared to 14.9% for the S&P 500 [15] - The company's net income for the last four quarters was $123 million, resulting in a net income margin of 1.2% compared to 11.6% for the S&P 500 [15] - The stock has experienced significant volatility, having tumbled 94.2% from its peak in March 2021 to December 2022, and is still recovering [16]